Fighting Cancer Smarter: The Power of Data

2024 ж. 17 Мам.
1 431 Рет қаралды

Fighting Cancer Smarter: The Power of Data | TARGET: Cancer Podcast | Ep. 61
Dr. Sanjay Juneja interviews David Hysong and Katherine Arline from Shepherd, a precision oncology platform. They discuss the limitations of traditional cancer treatment guidelines and the need for a more personalized approach. Shepherd uses multiomic data, including RNA sequencing, to assess a patient's unique tumor characteristics and recommend tailored therapies. They also consider collateral medications and potential side effects.
- - - -TimeStamps - - - -
00:00 Introduction
07:38 The birth of Shepherd
14:00 Shephard's approach to precision and tailored therapies
17:10 The potential for cures in cancer treatment
23:47 Genomic data to improve future treatments
- - - -
#cancertreatment #cancercure #medicine #precisiononcology
🔴Like, Subscribe, and Share to see more of this type of content!
- ABOUT DAVID HYSONG -
David is the Founder and CEO at SHEPHERD. He is an ardent champion of patient rights and a defiantly human approach to healthcare. He founded SHEPHERD with vision and a mandate- to build something that would give freedom, power, and a defiant hope back to patients when they had had none, and give them options when they had nowhere left to turn. David was diagnosed at 27 with a rare form of head and neck cancer, Adenoid Cystic Carcinoma, while a graduate student at Harvard University. He had recently completed officer selection for special operations in the U.S. military and had previously worked in Southeast Asia against human trafficking and the sexual enslavement of children. He leveraged the same commitment to working for systemic change and to help those who suffer to build SHEPHERD alongside are markable team of people equally passionate about saving patients lives. David is a Forbes 30 Under 30 honoree, Aspen Institute Spotlight Health Scholar, and Charles River Research Models in Drug Discovery Award Recipient. He is a graduate of Harvard University, St. John’s College, and Transylvania University and is also the founder of The Billion Life Project, which seeks to create market-driven solutions to humanity’s greatest suffering; and Rage to LIVE, which seeks to inspire others to overcome their own limitations to do the impossible - on behalf of others.
- ABOUT KATHERINE ARLINE -
Katherine Arline leads the development of SHEPHERD’s products. She is a graduate of Harvard University, where she studied economics, quantitative analysis, molecular and cellular biology, and bioinformatics. Prior to her work at SHEPHERD, Katherine spent fifteen years working in technology. She was running a big data startup in the Harvard Innovation Lab when a close family member was diagnosed with a rare brain cancer. Katherine and David met one month later and she asked to join the company to leverage her background in technology, data, and entrepreneurship to benefit high-need cancer patients.
- ABOUT DR SANJAY JUNEJA -
Dr. Sanjay Juneja is a triple board-certified Hematologist & Medical Oncologist serving as Chief of Oncology Service at Baton Rouge General Hospital, a social & news media personality known as the 'TheOncDoc' with over half a million followers, and one of fifteen social media doctors participating in the Healthcare Leaders in Social Media Round Table Series for the White House.
He has been featured by The Washington Post as well as dozens of national podcasts and regional news channels (PBS, CBS, NBC, NPR), and has given keynote speeches and partnered with American Cancer Society, BeTheMatch, Leukemia & Lymphoma Society, Harvard University, Louisiana Department of Health and several others.
- ABOUT xCURES -
xCures Inc. operates an AI-assisted platform that automatically retrieves and aggregates medical records from any US care site. Data is extracted and structured within 15 minutes, to offer a sophisticated view of a patient’s fully longitudinal health journey that encompasses everything from genomics to social determinants of health.
Learn more at: xcures.com/
Facebook: / xcures.platform
TikTok: / xcures.platform
Instagram: / xcures.platform
LinkedIn: / xcures
Twitter: / xcures_platform
TARGET: Cancer Podcast
Homepage: xcures.com/target-cancer-podc...
KZhead: / targetcancer
Spotify: open.spotify.com/show/2xMG5y5...
iTunes: podcasts.apple.com/us/podcast...
TuneIn:
tunein.com/podcasts/Technolog...
Google Podcasts:
podcasts.google.com/feed/aHR0...
Pandora:
www.pandora.com/podcast/targe...
Amazon Music:
music.amazon.com/podcasts/a80...

Пікірлер
  • To learn more about SHEPHERD Health, visit their website at www.shepherd.bio/

    @TargetCancer@TargetCancer25 күн бұрын
  • Thank you for the work you are all doing. I’m hopeful that this is the beginning of the answers we are all looking for.

    @Lilmodigly@Lilmodigly17 күн бұрын
    • Many thanks for your comment!

      @TargetCancer@TargetCancer16 күн бұрын
  • Wow, again another very exciting interview for the future treatments of cancer. Thank you so much again for giving us such great hope❤

    @lisa-eg8nx@lisa-eg8nx18 күн бұрын
    • We're glad you found the information helpful.

      @TargetCancer@TargetCancer18 күн бұрын
  • Btw TY for your podcasts. Many are gems.

    @CancerOutsideTheBox@CancerOutsideTheBox24 күн бұрын
    • Many thanks for your comment. We're glad you found the episodes helpful. Feel free to share the podcast with your contacts to help spread the knowledge.

      @TargetCancer@TargetCancer24 күн бұрын
  • I have cancer concerns, cant wait to watch this, thank u

    @blueridgemountainprepper2166@blueridgemountainprepper216627 күн бұрын
  • Great talk, it sounds so economical to treat a patient with this precision targeting of treatment

    @silvawade7127@silvawade712726 күн бұрын
    • Thank you for your feedback

      @TargetCancer@TargetCancer25 күн бұрын
  • Can you talk about supplements such as quercetin that weaken the tumor prior to chemo(oxaliplatin) ,allwoing it to be more effective

    @user-fo2cc7xx4y@user-fo2cc7xx4y27 күн бұрын
    • Perhaps exogenous ketones!

      @mpoharper@mpoharper27 күн бұрын
  • I have no mutations that are currently targetable. My insurance company wouldn’t pay for it.

    @mpoharper@mpoharper27 күн бұрын
  • I would live to get a second opinion with you. Do you take zoom appts? I live in Illinois

    @lisa-eg8nx@lisa-eg8nx18 күн бұрын
    • If you are asking about an appointment with Dr. Juneja, please visit: marybird.org/doctor/sjuneja/

      @TargetCancer@TargetCancer18 күн бұрын
    • Thank you!

      @lisa-eg8nx@lisa-eg8nx18 күн бұрын
  • I live in Toronto ontario canada. Can I arrange for genome testing with you. Please advise. Elisa

    @elisamarro7356@elisamarro73569 күн бұрын
    • Please reach out to Shepherd Health on their website: www.shepherd.bio

      @TargetCancer@TargetCancer9 күн бұрын
  • Stage IV rectal cancer here. Very broke, living, if you can call it that, on social security. I went to the Family Reach foundation mentioned and it looks like there's no money. Every single fund says "unavailable." Sigh.

    @CancerOutsideTheBox@CancerOutsideTheBox24 күн бұрын
    • You can also check these options: www.cancer.net/navigating-cancer-care/financial-considerations/financial-resources Wishing you the best.

      @TargetCancer@TargetCancer24 күн бұрын
    • ​@@TargetCancer if I live in Toronto ontario canada can I get the rna sequencing done from here via blood samples. Please provide details. Thanks

      @elisamarro7356@elisamarro73569 күн бұрын
KZhead